UK - Liverpool Seed Fund invests £250,000 in health screening company
The Merseyside Special Investment Fund's Liverpool Seed Fund has completed an investment of ТЃ250,000 in health screening company Gemini Biomedical Ltd.
The financing will be used to bring the company's new pharmacy-based medical screening service HealthTrack to market in the UK. The process involves combining basic information such as height, weight and blood pressure with data obtained from an oral swab test, which collects blood derived fluid found in the gums. The technology replaces existing blood tests and can detect a variety of conditions including HIV and Hepititis. Trials have already proved successful in Dublin and the service will shortly be rolled-out across the whole of Ireland.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








